September
2006 »
J&J Plans A Pill For A New Sexual Dysfunction
13 September, 2006
JOHNSON & JOHNSON WANTS TO be the
next big player in men's sexual dysfunction. The pharmaceutical
giant is developing a pill to prevent premature ejaculation.
J&J's potential entry would likely appeal to younger
men, who most often suffer this malady. Competitors
in the category--Pfizer's Viagra, Eli Lilly's Cialis,
and GlaxoSmithKline/Bayer's Levitra--all address erection
issues, which are more prevalent in older men.
Premature ejaculation--the most common
male sexual dysfunction--affects between 27 and 34 percent
of all men, according to the American Urological Association.
To read more, Visit:
http://publications.mediapost.com/index.cfm?fuseaction=Articles.showArticleHomePage&art_aid=48066 |
